| Previous Close | 0.57 |
| Open | 0.56 |
| Day High | 0.63 |
| Day Low | 0.56 |
| 52-Week High | 2.89 |
| 52-Week Low | 0.48 |
| Volume | 712,405 |
| Average Volume | 271,548 |
| Market Cap | 5.63M |
| PE | -1.61 |
| EPS | -0.38 |
| Moving Average 50 Days | 0.59 |
| Moving Average 200 Days | 1.43 |
| Change | 0.04 |
NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products
GlobeNewswire Inc.
Mar 10, 2026 12:45 PM GMT
Transaction expected to approximately triple NEXGEL’s annual revenue to about $35 million and is expected to make the Company immediately profitable upon closing Licensing and acquiring a diversified suite of 6 established regenerative biomaterial pr
NEXGEL Announces Financing of $1.797 Million Relating to an Acquisition Targeted to Close in the First Quarter of 2026, Subject to the Completion of Due Diligence
GlobeNewswire Inc.
Feb 10, 2026 2:00 PM GMT
LANGHORNE, Pa., Feb. 10, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products
NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor
GlobeNewswire Inc.
Dec 16, 2025 1:00 PM GMT
LANGHORNE, Pa., Dec. 16, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products